Vaccitech, the company that owns the technology behind the Oxford/AstraZeneca coronavirus vaccine, co-founded by Oxford scientists, goes public with a valuation of $464m:
“As they say in biotech, take money when it’s available”.
ft.com/content/031b16… https://t.co/eLGp2hEJu0
RT @BJMbraun: How to be an effective political economist: Laser focus on the neuralgic points of the state-market nexus, follow
May 18, 2023
RT @BJMbraun: How to be an effective political economist: Laser focus on the neuralgic points of the state-market nexus, follow the money,…